- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fonar bags patent for breast MRI
MRI vendor Fonar of Melville, NY, has received a patent for MRIbreast scanning of multiple patients, the company reported thismonth. The technique could be used with Fonar's new Quad seriesof MRI magnets, which are open on all four sides and can be
MRI vendor Fonar of Melville, NY, has received a patent for MRIbreast scanning of multiple patients, the company reported thismonth. The technique could be used with Fonar's new Quad seriesof MRI magnets, which are open on all four sides and can be fittedwith up to four patient beds, with a screen between the patientsas they are shuttled through the magnet.
Fonar hopes that the multiple-bed configuration will increasethe throughput and reduce the cost of breast MRI scanning enoughto make it competitive with conventional x-ray mammography. Theconfiguration allows as many as 10 patients to be scanned in anhour, according to Fonar.
Fonar has aggressively defended other MRI patents against whatit claims are infringements by other vendors. It has settled claimsagainst Hitachi and Philips and is involved in litigation withGE, Siemens, and Toshiba.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
